A prognostic model for resectable acral melanoma patients on the basis of preoperative inflammatory markers
A prognostic model for resectable acral melanoma patients on the basis of preoperative inflammatory markers
复制标题
基于术前炎症标志物的可切除肢端黑色素瘤患者的预后模型
DOI:
10.1097/cmr.0000000000000365
复制
发表时间:
2017-06
影响因子:
2.2
通讯作者:
Zhang Xiao-Shi
中科院分区:
文献类型:
--
作者:
Wang Yao;Wen Xi-Zhi;Ba Hong-Jun;Li Dan-Dan;Ding Ya;Wang Ke-Feng;Li Jing-Jing;Zhang Xiao-Shi
Acral melanoma is a rare disease, but is common in Asia. Knowledge of its prognostic indicators is limited. Growing evidence indicates that inflammation plays a critical role in the development and progression of acral melanoma. We developed a novel prognostic model on the basis of preoperative inflammatory markers and examined its prognostic value in a cohort of patients. This retrospective study included 232 acral melanoma patients who underwent radical surgical resection between 2000 and 2010 at the Sun Yat-sen University Cancer Center. Significant predictive factors were identified by multivariate Cox regression analyses, and a prognostic model on the basis of these variables was constructed to predict survival. Kaplan–Meier curves were plotted to estimate overall survival. Multivariate analyses showed that C-reactive protein, albumin/globulin ratio, age, lactic dehydrogenase, and lymph node positivity were related independently to survival. After analyzing these variables, we classified patients into three risk groups. The new prognostic model identified three categories of patients with different prognoses (P<0.001) and significantly stratified patient prognosis into different tumor stages. The area under the curve of the new prognostic model was 0.684 (95% confidence interval: 0.620–0.743), which was significantly higher than that of the other variables (P<0.001). C-reactive protein and albumin/globulin ratio were independently related to survival in our study population and the prognostic model developed using inflammatory-based scores was useful in stratifying patients into different risk groups. Thus, this model will be a valuable complement to the 2009 American Joint Committee on Cancer staging for Asian patients with acral melanoma.
登录
查看更多内容
影响因子:
4.7
作者:
Mahmoud, Fade Aziz;Rivera, Nilo I
通讯作者:
Rivera, Nilo I
影响因子:
--
作者:
Bradford, Porcia T.;Goldstein, Alisa M.;McMaster, Mary L.;Tucker, Margaret A.
通讯作者:
Tucker, Margaret A.
影响因子:
3.7
作者:
Li YJ;Li ZM;Xia Y;Huang JJ;Huang HQ;Xia ZJ;Lin TY;Li S;Cai XY;Wu-Xiao ZJ;Jiang WQ
通讯作者:
Jiang WQ
影响因子:
3.6
作者:
Schneider, Samantha L.;Ross, Andrew L.;Grichnik, James M.
通讯作者:
Grichnik, James M.
DOI:
10.47102/annals-acadmedsg.v41n1p17
发表时间:
2012-01
期刊:
Annals of the Academy of Medicine, Singapore
影响因子:
--
作者:
H. Lee;W. Chay;M. Tang;M. Chio;S. Tan
通讯作者:
H. Lee;W. Chay;M. Tang;M. Chio;S. Tan